Recent News

• 02.26.2025 - GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
• 02.25.2025 - GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing
• 02.21.2025 - GRAIL to Present at TD Cowen 45th Annual Health Care Conference
• 02.20.2025 - GRAIL Reports Fourth Quarter and Full Year 2024 Financial Results
• 02.12.2025 - GRAIL to Announce Fourth Quarter 2024 Financial Results
• 02.12.2025 - GRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System
• 01.13.2025 - Patient Reported Outcomes for GRAIL's Galleri® Multi-Cancer Early Detection Blood Test Published in Lancet Oncology
• 12.18.2024 - GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference
• 12.04.2024 - Doug Schenkel
• 12.04.2024 - Tejas Savant

Recent Filings

• 02.20.2025 - 8-K Current report
• 02.20.2025 - EX-99.1 EX-99.1
• 02.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.15.2025 - EX-99.1 EX-99.1
• 01.15.2025 - 8-K Current report